2021
DOI: 10.1002/brb3.2231/v3/response1
|View full text |Cite
|
Sign up to set email alerts
|

Author response for "The GLP-1/GIP dual-receptor agonist DA5-CH inhibits the NF-kappa B inflammatory pathway in the MPTP mouse model of Parkinson's disease more effectively than the GLP-1 single-receptor agonist NLY01"

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles